scientific programme
27
Monday, 23 June 2014
S-03-002
Roles of genetics-based animal models in
drug development in bipolar disorder
Tracey Petryshen, USA
S-03-003
Targeting synaptic and neural plasticity to
develop novel, improved, therapeutics for
severe mood disorders
Husseini Manji, USA
S-03-004
Ebselen as a novel IMPase inhibitor as a
lithium mimetic
Grant Churchill, United Kingdom
N. Singh, S. Vasudevan, J. Thomas, A. Halliday,
I. Antoniadou, T. Sharp, A. Sharpley, P. Cowen
Learning Objectives:
This symposium will
provide delegates with an update on our un-
derstanding of bipolar disorders.
S-04
SYMPOSIUM
10:00–12:00
Room 11
Track: Translational
Topic: Attention deficit disorders (D)
Paediatric disorders characterised by ag-
gression and/or social impairment: From
preclinical research to clinical subtyping
Chair:
Klaus-Peter Lesch, The Nether-
lands
Co-Chair: Barbara Franke, The Netherlands
S-04-001
Gene-by-environment interaction and epi-
genetic mechanisms in aggression: Lessons
from animal models
Klaus-Peter Lesch, The Netherlands
S-04-002
Screening for novel aggression therapeutics
in zebrafish
William Norton, United Kingdom
S-04-003
Genetics of adult ADHD and antisocial per-
sonality disorder
Andreas Reif, Germany
S-04-004
Overlap and differences between ADHD
and conduct disorder: Imaging genetics
approaches
Barbara Franke, The Netherlands
Learning Objectives:
This symposium will
provide delegates with an update on our un-
derstanding of ADHD.
S-05
SYMPOSIUM
10:00–12:00
Room 8+15
Track: Translational
Topic: Neuroimaging (B)
Alcohol dependence: Neuroimaging and
pharmacology
Chair:
Andrew J. Greenshaw, Canada
Co-Chair: Wolfgang Sommer, Germany
S-05-001
Mapping of functional brain activity in alco-
hol drinking rats using manganese-enhanced
magnetic resonance imaging
Petri Hyytiä, Finland
M. Dudek, U. Abo-Ramadan
S-05-002
Increased brain activity during protracted
abstinence as a predictor for relapse beha
viour in alcohol dependent rats
Wolfgang Sommer, Germany
W. Weber-Fahr, K. Mann, D. Hermann, P. Hy
ytiä, S. Canals, M. Brown, M. Meinhardt
S-05-003
Alcohol use disorder: Structural and func-
tional brain changes in abstinence and ef-
fects of naltrexone
Andrew J. Greenshaw, Canada
S-05-004
NK1 and dopamine D3 antagonists as new
approaches to alcohol dependence
David Nutt, United Kingdom
Learning Objectives:
This symposium reviews
progress in understanding the causes, conse-
quences and treatment of alcoholism.
JS-01
SYMPOSIUM
10:00–12:00
Room 10
Japanese Session: Current research topics
in schizophrenia and future perspectives
Chair:
Hitoshi Hashimoto, Japan
Co-Chair: Norio Ozaki, Japan
JS-01-001
Cognitive impairment and response to anti-
psychotic drug treatment as intermediate phe-
notypes in schizophrenia: Integrating animal
model, genetic and clinical trial approaches
Herbert Meltzer, USA
Y. Oyamada, L. Rajagopal, J. Li
